The federal agency that oversees the 340B program formally warned Johnson & Johnson (J&J) that it must “cease implementation of its rebate proposal immediately and to inform HRSA no later than September 30, 2024, in order to provide adequate notice to covered entities.” Click here to access the letter HHS sent to J&J. In addition, a bipartisan group of six Representatives began circulating for signatures a letter to HHS urging the agency to stop J&J’s rebate model.
